Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy - Wikidata - wikimedia - TriplyDB

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

http://www.wikidata.org/entity/Q36977059

about

Micronutrients in Oncological Intervention Mechanisms involved in the development of chemotherapy-induced neuropathy Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology Chemotherapy-induced neuropathies-a growing problem for patients and health care providers Mitotoxicity in distal symmetrical sensory peripheral neuropathies Paclitaxel-induced increase in mitochondrial volume mediates dysregulation of intracellular Ca2+ in putative nociceptive glabrous skin neurons from the rat Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Therapeutic strategies for cancer treatment related peripheral neuropathies.Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.Platinum-induced neurotoxicity and preventive strategies: past, present, and future Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).The search for treatments to reduce chemotherapy-induced peripheral neuropathy.Enhancing nurse contributions to SWOG clinical trials.Appropriate use of complementary and alternative medicine approaches in gynecologic cancers.Management options for established chemotherapy-induced peripheral neuropathy.Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic strategies and directions for future research.Altered Blood Flow Response to Small Muscle Mass Exercise in Cancer Survivors Treated With Adjuvant Therapy Unmonitored use of herbal medicine by patients with breast cancer: reframing expectations.BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture.Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis.Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.

P2860

Q26764839-2268FF13-A633-4B59-B189-9E980476350B Q26824380-74393A61-E9AD-46C7-8B00-6D1A4FB60C99 Q28270819-10686021-28D8-44C9-A34F-C77B53996E17 Q28551798-AB2F10CA-FDC1-4787-B0E4-405AEB650537 Q28818565-B7FD1969-C88C-4B68-A2DD-36E315E0026B Q28834071-9A10161B-CF0F-44CD-9FA2-AD7BE5A28B2B Q29248252-D7EC7359-F675-4D39-A089-9077AEC1B1F3 Q30234688-26EF9E0F-6207-4ABB-93FF-E99CDEACE570 Q30372504-D18D0847-B614-44DD-B012-4F6ADDEFCD42 Q33693343-B7BBB942-0A21-400A-9A1F-94C686C68BC6 Q33717608-55A20CC2-E48D-4CA6-AF24-935980BFDE7D Q33744706-EC08229F-CAE6-422C-96F2-1BE6A6A5FBD2 Q33824948-00E99A29-8233-4337-B1D1-810A7567621F Q34245549-B1A17ADB-0BC2-4DCE-8660-2C807CD0F36E Q34433406-07FBDF83-006B-47B5-9BED-F2861F4B6E3D Q34458581-A9A3F1D2-25AC-43D8-8FE0-85C2268F5774 Q34685307-DB5C2695-9D77-4C34-804C-4017C02E0F7B Q35121171-C25C4B64-10E4-4E3F-9891-21460CF5080B Q35345734-D1AEFC9D-63B8-4122-83AA-67071D1E6550 Q35778696-D9929EB4-DE72-433F-AC9F-F12FD96C23B5 Q36226275-6CAB5B9B-BBF1-4B13-B6C2-EF242C1093F9 Q37227426-CA6F8304-B06F-487C-AE2D-36EF9AD56DEA Q37301431-9DA232BD-3DFD-4F64-A973-28653450AE30 Q37364316-49C347D3-B90B-40C7-B7AA-EBEFA85D9720 Q37399781-406F8AB5-1656-42D5-9EE2-FA9F2381D319 Q37410650-3DABB81C-B5E5-4BD1-A059-9A7D45DE8281 Q37651986-639F8D5B-000F-4BC8-AD6D-5CD9CE2FA0D8 Q38176506-1CDA6588-A924-4407-B170-0B5A84B0385F Q38216217-ECB98032-41BA-406F-99A6-29B4D4CD3E20 Q38264622-E259AD70-53F1-4BA4-A3CA-96F536E84656 Q38426849-08513462-AE77-48C1-B739-B9A6F16308BC Q38716340-EFE916DD-A7EE-4825-BF6B-C67CCBC48587 Q38769139-B4631EB8-8319-4C1E-84E6-0FBD875E7AC0 Q38973438-385E066E-2163-40B9-A6F4-227C5C349B40 Q39153420-0EFAA882-9619-4553-A8B6-889D34FA1924 Q39236303-C25EC455-451A-4046-86CC-52017A659D42 Q39283600-FFE99132-1AB2-4CF8-8849-87E1C928A684 Q41346602-C6633EC8-0DFA-445A-ADE9-AECFF3C2BB60 Q47103663-E17BBF9F-A3CB-41C7-B246-62B21FABD6C9 Q47552411-9057ACA3-A5BA-41C9-9FEE-03DE59E0D778

P2860

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

http://www.wikidata.org/entity/Q36977059

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Randomized double-blind placeb ...... adjuvant breast cancer therapy

@en

type

label

Randomized double-blind placeb ...... adjuvant breast cancer therapy

@en

prefLabel

Randomized double-blind placeb ...... adjuvant breast cancer therapy

@en

P1433

Q36977059-B71C794C-5697-496D-9EFD-804422E7159E

P1476

Q36977059-E0F0308E-72E0-4E9F-B58F-B6745FEA07BB

P2093

Q36977059-05B402D3-99FE-4FA1-947A-942D3AA29070

Q36977059-0898ADF3-40E5-4716-A085-CFB5EE8E9D98

Q36977059-1045E7F3-D9BB-48D7-8420-AD98CE03B4AA

Q36977059-400C0F47-C096-4449-AC33-4022098013BC

Q36977059-470549DC-37B0-4F8A-96D0-8C8C458EF2E4

Q36977059-4AF95EB9-7D14-4CA6-8937-28D6E9130316

Q36977059-92367518-9C49-45A7-857C-FD3364D24693

Q36977059-AEB3AFDA-ADC8-4C0A-8D0A-FA55ADB25CFB

Q36977059-D938C779-6173-4892-AFD3-4D7A612E0F98

Q36977059-E4077BA7-9B59-4763-BCB9-E217FF300501

P2860

Q36977059-012CA0E4-B5F1-4A9B-87AE-522399EBE6DB

Q36977059-0E3F6F75-168A-497D-8BE0-94AB3BE00420

Q36977059-10F3382C-F13E-497A-A240-76113DB11A07

Q36977059-2292F7E0-75E5-4474-84FC-F6287D09A2B6

Q36977059-2AC7A2AD-300A-45DB-A5E1-AFB78FA1E5AE

Q36977059-2BDD6ABF-3180-4F09-BC89-F9C0BE948BAE

Q36977059-2E4698DD-941C-4672-BDF7-A8C58B2CBB24

Q36977059-32B14516-15C1-4C14-B635-CABEFC34243F

Q36977059-58031F85-DFB3-4D56-AF9C-5132EF0877F6

Q36977059-5B0C7638-90B4-4B9B-BE1E-5898D7395D1F

P304

Q36977059-DDB33A7A-C9F1-4324-92F5-28F11082DC83

P31

Q36977059-D7C07387-59DC-4FEE-85DC-36C4FD40D1F0

P356

Q36977059-7472B0F1-6E05-4A23-8EDF-8899ED6C1CC6

P407

Q36977059-76F3CA37-7094-48D2-911B-81140302F974

P433

Q36977059-DE913582-1058-40B3-81D4-0F52184DC5E1

P478

Q36977059-A8261AF4-B1A7-420E-BA9C-77AC9461EED4

P50

Q36977059-7D160687-C5DD-4142-B23B-27E4C3B7E447

P577

Q36977059-BB37A13C-0698-42AD-967F-7454684F3449

P5875

Q36977059-B76C6A4D-D829-452C-8F11-1104B59C30F8

P698

Q36977059-D5801BEF-8D8F-42A7-878B-12B489C6B87D

P921

Q36977059-1494398F-FA9E-4D13-AC2C-E513124AE898

P932

Q36977059-CEB7A8A5-ECD6-40F4-ACB6-5F2F09A2DBC3

P356

JCO.2012.44.8738

P1433

Journal of Clinical Oncology

P1476

Randomized double-blind placeb ...... adjuvant breast cancer therapy

@en

P2093

Carol M Moinpour

http://www.w3.org/2001/XMLSchema#string

Danielle Awad

http://www.w3.org/2001/XMLSchema#string

Danika L Lew

http://www.w3.org/2001/XMLSchema#string

Frank L Meyskens

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Heather Greenlee

http://www.w3.org/2001/XMLSchema#string

James L Wade

http://www.w3.org/2001/XMLSchema#string

Joseph M Unger

http://www.w3.org/2001/XMLSchema#string

Katherine D Crew

http://www.w3.org/2001/XMLSchema#string

Kathy S Albain

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.

A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.

Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy.

Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.

P304

2627-2633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2012.44.8738

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Dawn L Hershman

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237017884

http://www.w3.org/2001/XMLSchema#string

P698

23733756

http://www.w3.org/2001/XMLSchema#string

P921

P932

3699727

http://www.w3.org/2001/XMLSchema#string